Stock 1666 TONG REN TANG TECHNOLOGIES CO. LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Tong Ren Tang Technologies Co. Ltd.

Equities

1666

CNE100000585

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:35 2024-04-19 am EDT 		5-day change 1st Jan Change
4.71 HKD -0.21% Intraday chart for Tong Ren Tang Technologies Co. Ltd. -6.73% -28.09%
Mar. 22 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 05 China Permits Clinical Trial of Tong Ren Teng's Anti-Blood Stasis Drug MT

Business Summary

Tong Ren Tang Technologies Co Ltd is a China-based company mainly engaged in the manufacture and sale of traditional Chinese medicine products. The Company's main businesses includes the production, retail and wholesale of traditional Chinese medicine products and health care products and the provision of traditional Chinese medicine diagnosis and treatment services. The Company is also engaged in the production, processing and acquisition of Chinese herbal medicines, drug sales, medical services and advertising. The Company mainly distributes its products in the domestic market and overseas markets.

Number of employees: 4,030

Sales per Business

HKD in Million2021Weight2022Weight Delta
The Company
57.6 %
3,926 60.3 % 4,012 57.6 % +2.17%
Tong Ren Tang Chinese Medicine
23.9 %
1,556 23.9 % 1,664 23.9 % +6.96%
All Others
18.5 %
1,026 15.8 % 1,292 18.5 % +25.85%

Sales per region

HKD in Million2021Weight2022Weight Delta
China
81.3 %
5,377 82.6 % 5,662 81.3 % +5.31%
International
18.7 %
1,132 17.4 % 1,306 18.7 % +15.34%

Managers

Managers TitleAgeSince
Jia Fu Chen CEO
 Chief Executive Officer 55 23-06-14
Guan Zhao Han LAW
 General Counsel 45 -
Shu Wu Zhao PRN
 Corporate Officer/Principal 42 -
Yijun Li SEC
 Corporate Secretary 40 23-05-03
Gui Qin Guo PRN
 Corporate Officer/Principal 59 -
Cun Ying Liu PRN
 Corporate Officer/Principal 59 -
Jian Bai PRN
 Corporate Officer/Principal 64 -
Mei Yee Yung SEC
 Corporate Secretary - 23-05-03

Members of the board

Members of the board TitleAgeSince
Leung Huel Ting BRD
 Director/Board Member 70 00-10-10
Ching Har Chan BRD
 Director/Board Member 67 18-06-11
Yuan Jing Zhan BRD
 Director/Board Member 80 18-06-11
Tao Jin BRD
 Director/Board Member 55 -
Shu Bing Di CHM
 Chairman 49 Jan. 21
Zhi Mei Feng BRD
 Director/Board Member 54 21-12-15
Li Feng BRD
 Director/Board Member 48 22-12-21
Chun Rui Wang BRD
 Director/Board Member 41 23-02-15
Jia Fu Chen CEO
 Chief Executive Officer 55 23-06-14

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 652,080,000 0 0 45.64 %
Stock B 1 628,704,000 584,575,000 ( 92.98 %) 0

Shareholders

NameEquities%Valuation
HHLR Advisors Ltd.
7.581 %
47,663,000 7.581 % 30 M $
Sai Nan Yuan
5.683 %
35,732,000 5.683 % 22 M $
Beijing Tong Ren Tang Group Co Ltd
1.217 %
7,649,000 1.217 % 5 M $
Sumitomo Mitsui Asset Management Co., Ltd.
0.9324 %
5,862,000 0.9324 % 4 M $
UBS Asset Management (Hong Kong) Ltd.
0.9162 %
5,760,000 0.9162 % 4 M $
UBS SDIC Fund Management Co., Ltd.
0.1848 %
1,162,000 0.1848 % 723 055 $
Crédit Mutuel Asset Management SA
0.1432 %
900,000 0.1432 % 560 025 $
Fullgoal Fund Management Co., Ltd.
0.1384 %
870,000 0.1384 % 541 358 $
Capital International KK
0.1336 %
840,000 0.1336 % 522 690 $
Dimensional Fund Advisors Ltd.
0.1018 %
640,224 0.1018 % 398 379 $
NameEquities%Valuation
BEIJING TONGRENTANG CO., LTD
92.01 %
600,000,000 92.01 % 373 M $
Beijing Tong Ren Tang Group Co Ltd
1.454 %
9,480,000 1.454 % 6 M $

Holdings

NameEquities%Valuation
BEIJING TONG REN TANG CHINESE MEDICINE COMPANY LIMITED
38.05%
 318,540,000 38.05% 364,269,602 $

Company contact information

Tong Ren Tang Technologies Co., Ltd.

No.20 Nansanhuan Zhonglu Fengtai District

100079, Beijing

+86 10 8763 2888

http://www.tongrentangkj.com
address Tong Ren Tang Technologies Co. Ltd.(1666)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Alternative Medicine

Sales per Business

Sales per region

Ratings for Tong Ren Tang Technologies Co. Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
4.353 CNY
Average target price
6.058 CNY
Spread / Average Target
+39.14%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

1st Jan change Capi.
TONG REN TANG TECHNOLOGIES CO. LTD. Stock Tong Ren Tang Technologies Co. Ltd.
-28.09% 772M
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+40.86% 6.16B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-16.30% 4.49B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-9.93% 3.17B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
-1.58% 3.01B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-1.70% 2.57B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+37.23% 1.8B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-12.78% 1.62B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
+1.02% 1.56B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-12.97% 1.53B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. 1666 Stock
  4. Company Tong Ren Tang Technologies Co. Ltd.